Literature DB >> 6610087

Cellular cytotoxicity against autologous hepatocytes in alcoholic liver disease.

T Poralla, T H Hütteroth, K H Meyer zum Büschenfelde.   

Abstract

We tested lymphocyte cytotoxicity against autologous hepatocytes in patients with alcoholic liver disease (ALD). The following cytotoxicity values were found (mean +/- SEM): alcohol-induced steatosis with or without fibrosis 16.5 +/- 2% (n = 29), alcoholic cirrhosis 28 +/- 4% (n = 13), controls with normal liver histology or minimal changes 6 +/- 2% (n = 11). The differences were statistically significant (both forms of ALD versus controls p less than 0.005). T-cell as well as non-T-cell-enriched lymphocyte fractions showed increased cytotoxicity in ALD. We did not observe a correlation between cellular cytotoxicity and the degree of biochemical or histological alterations within the groups tested. Thus, our study demonstrating enhanced cellular cytotoxicity against autologous hepatocytes in ALD further supports the hypothesis that cellular immune reactions are involved in the pathogenesis of ALD, especially of alcoholic cirrhosis.

Entities:  

Mesh:

Year:  1984        PMID: 6610087     DOI: 10.1111/j.1600-0676.1984.tb00915.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  Activated CD-8 cells and HLA DR expression in alcoholics without overt liver disease.

Authors:  R T Cook; M J Garvey; B M Booth; J A Goeken; B Stewart; M Noel
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

2.  Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

Authors:  U McKeever; C O'Mahony; C A Whelan; D G Weir; C Feighery
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

3.  Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde.

Authors:  Michael J Duryee; Lynell W Klassen; Bonnie L Jones; Monte S Willis; Dean J Tuma; Geoffrey M Thiele
Journal:  Int Immunopharmacol       Date:  2008-04-28       Impact factor: 4.932

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.